Indian Pharmas Seeking Foreign Acquisitions Find Selectivity Need
This article was originally published in PharmAsia News
Indian drug makers are finding large foreign acquisitions harder to find, leading some firms to be more sophisticated in their selection process. One consultant said Indian companies have specific objectives about the part of the market in which they wish to acquire players. That selectivity could include acquisitions of patents, a brand or its distribution as well as a sub-segment of the market. Although large acquisitions are expected to continue, companies seeking to acquire others will have to look beyond conventional considerations in making the decision, the consultant says. (Click here for more
You may also be interested in...
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.
Rosa DeLauro prevails over fellow Democrats Debbie Wasserman Schultz and Marcy Kaptur for Appropriations chair. Frank Pallone gets unanimous support from Democrats to continue as Energy and Commerce chair.
The US Medicare agency is offering more lower-cost alternative sites for 2021 surgical procedures to be covered under its OPPS and ASC final rule.